A β-cyclodextrin "click cluster" decorated with seven paramagnetic chelates containing two water exchange sites

Bioconjugate Chemistry

Volumn 19, Issue 8, 2008, Pages 1505-1509

  Bryson, Joshua M ^a   Chu, Wen Jang ^c   Lee, Jing Huei ^b,c   Reineke, Theresa M ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b 705 Engineering Research Center   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATION; CYCLODEXTRINS; DIAGNOSIS; MACROMOLECULES; SCAFFOLDS; SCANNING;

CONTRAST AGENT; CYCLODEXTRIN CORE; DIETHYLENETRIAMINETETRAACETIC ACID; FUNCTIONALIZED; HIGH MAGNETIC FIELDS; LUMINESCENCE MEASUREMENTS; PARAMAGNETIC CHELATES; PROTECTING GROUP; RELAXIVITY; WATER EXCHANGE;

PARAMAGNETISM;

ACETIC ACID DERIVATIVE; BETA CYCLODEXTRIN DERIVATIVE; CHELATE; DEUTERIUM; GADOLINIUM; GADOLINIUM PENTETATE; LANTHANIDE; WATER;

ARTICLE; CLUSTER ANALYSIS; DISPERSION; DRUG DESIGN; DRUG STRUCTURE; LUMINESCENCE; MACROMOLECULE; MAGNETIC FIELD; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIODIAGNOSTIC EQUIPMENT AND SUPPLIES; TITRIMETRY;

EID: 50249140097     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc800200q     Document Type: Article

References (27)

1. Lauffer, R. B. (1987) Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem. Rev. 87, 901-927.
2. Tóth, É., Merbach, A. E., Helm, L. (2001) Relaxivity of Gd(III) complexes: Theory and mechanism, Wiley, Chichester.
3. Caravan, P., McMurry, T. J., and Lauffer, R. B. (1999) Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications. Chem. Rev. 99, 2293-2352.
4. Caravan, P. (2006) Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem. Soc. Rev. 35, 512-523.
5. III complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field. Dalton Trans. 9, 1195-1202.
6. Pierre, V. C., Botta, M., Aime, S., and Raymond, K. N. (2006) Fe(III)-templated Gd(III) self-assemblies-A new route toward macromolecular MRI contrast agents. J. Am. Chem. Soc. 128, 9272-9273.
7. Tóth, É., Helm, L., and Merbach, A. E. (2004) Metal complexes as MRI contrast enhancement agents. Comprehensive Coordinate Chemistry II 9, 841-881.
8. Mohs, A. M., and Lu, Z. -R. (2007) Gadolinium(III)-based blood-pool contrast agents for magnetic resonance imaging: status and clinical potential. Expert Opin. Drug Delivery 4, 149-164.
9. Torchilin, V., Babich, J., and Weissig, V. (2000) Liposomes and micelles to target the blood pool for imaging purposes. J. Liposome Res. 10, 483-499.
10. Mohs, A. M., Wang, X., Goodrich, K. C., Zong, Y., Parker, D. L., and Lu, Z. -R. (2004) PEG-g-poly(GdDTPA-co-L-cystine): A biodegradable macromolecular blood pool contrast agent for MR imaging. Bioconjugate Chem. 15, 1424-1430.
11. Langereis, S., Dirksen, A., Hackeng, T. M., Van Genderen, M. H. P., and Meijer, E. W. (2007) Dendrimers and magnetic resonance imaging. New J. Chem. 31, 1152-1160.
12. Ranganathan, R. S., Fernandez, M. E., Kang, S. I., Nunn, A. D., Ratsep, P. C., Pillai, K. M. R., Zhang, X., and Tweedle, M. F. (1998) New multimeric magnetic resonance imaging agents. Invest. Radiol. 33, 779-797.
13. Srinivasachari, S., Fichter, K. M., and Reineke, T. M. (2008) Polycationic β-cyclodextrin "click clusters": Monodisperse and versatile scaffolds for nucleic acid delivery. J. Am. Chem. Soc. 130, 4618-4627.
14. Bartlett, D. W., and Davis, M. E. (2008) Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles. Biotechnol. Bioeng. 99, 975-985.
15. Bellocq, N. C., Pun, S. H., Jensen, G. S., and Davis, M. E. (2003) Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery. Bioconjugate Chem. 14, 1122-1132.
16. Aime, S., Botta, M., Fedeli, F., Gianolio, E., Terreno, E., and Anelli, P. (2001) High-relaxivity contrast agents for magnetic resonance imaging based on multisite interactions between a β-cyclodextrin oligomer and suitably functionalized Gd(III) chelates. Chem.-Eur. J. 7, 5261-5269.
17. Song, Y., Kohlmeir, E. K., Meade, T. J. (2008) Synthesis of multimeric MR contrast agents for cellular imaging. J. Am. Chem. Soc. ASAP DOI:10.1021/ja0777990.
18. Ruloff, R., van Koten, G., and Merbach, A. E. (2004) Novel heteroditopic chelate for self-assembled gadolinium(III) complex with high relaxivity. Chem. Commun. 7, 842-843.
19. 1H NMRD studies. Inorg. Chim. Acta 275, 15-23.
20. Davies, J. S., and Al-Jamri, L. (2002) Synthesis of N-Boc-Nε-tetrabenzyl-DTPA-L-lysine and Nε-Fmoc-Nε- tetra-t-butyl-DTPA-L-lysine, building blocks for solid phase synthesis of DTPA-containing peptides. J. Pept. Sci. 8, 663-670.
21. Boger, J., Corcoran, R. J., and Lehn, J. -M. (1978) Cyclodextrin chemistry. Selective modification of all primary hydroxyl groups of α- and β-cyclodextrins. Helv. Chim. Acta 61, 2190-2218.
22. Ashton, P. R., Koniger, R., Stoddart, J. F., Alker, D., and Harding, V. D. (1996) Amino acid derivitives of beta-cyclodextrin. J. Org. Chem. 61, 903-908.
23. Rostovtsev, V. V., Green, L. G., Fokin, V. V., and Sharpless, K. B. (2002) A stepwise Huisgen cycloaddition process: Copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. Angew. Chem., Int. Ed. 41, 2596-2599.
24. Mynar, J. L., Choi, T. -L., Yoshida, M., Kim, V., Hawker, C. J., and Fréchet, J. M. J. (2005) Doubly-dendronized linear polymers. Chem. Commun. 5169-5171.
25. Johnson, D. A. (1980) Principles of lanthanide chemistry. J. Chem. Educ. 57, 475-476.
26. Supkowski, R. M., and Horrocks, W. D., Jr. (2002) On the determination of the number of water molecules, q, coordinated to europium(III) ions in solution from luminescence decay lifetimes. Inorg. Chim. Acta 340 44-48.
27. Urbanczyk-Pearson, L. M., Fermia, F. J., Smith, J., Parigi, G., Duimstra, J. A., Eckermann, A. L., Luchinat, C., and Meade, T. J. (2008) Mechanistic investigation of β-galactosidase-activated MR contrast agents. Inorg. Chem. 47, 56-68.